8-K: Liminatus Pharma, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-11-03 AccNo: 0001104659-26-122012 Size: 461 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se
Filed: 2026-11-03 AccNo: 0001104659-26-122012 Size: 461 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se